Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Holistic Digital Health Engagement and Risk Quantification

Videos and Podcasts | January 28, 2021 | Impetus Digital

Matt Park, Vice President & General Manager (North America) at Dacadoo, explores digital health engagement and health risk quantification in the COVID-19 era, including the roles of gamification, big data,...

Can Science Save Us?

Videos and Podcasts | January 28, 2021 | Impetus Digital

Dr. Mark Poznansky, Founder/Blogger at Saved By Science explores the importance of improving health literacy among the general population, along with the scientific and technological innovations that he believes could help save...

Onyx Health Launch National Competition for Life Science SMEs

Press Releases | January 27, 2021 | Onyx Health

Healthcare marketing communications agency Onyx Health are launching a national competition #ThinkBig to help health and life sciences SMEs bounce back from the COVID-19 crisis

What does the future hold for Medical Affairs?

White Papers and Resources | January 27, 2021 | Blue Latitude Health

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Wilmington Healthcare appoints new Head of Digital

Press Releases | January 26, 2021 | Wilmington Healthcare

Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...

Mistrust in medical research: a patient perspective

White Papers and Resources | January 22, 2021 | Blue Latitude Health

The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...

Real-world evidence: breaking boundaries in rare disease

White Papers and Resources | January 22, 2021 | Blue Latitude Health

Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

The heavy toll of COVID-19 on cancer patients

White Papers and Resources | January 22, 2021 | Blue Latitude Health

We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Unpacking rare diseases in the first edition of Delta magazine

White Papers and Resources | January 22, 2021 | Blue Latitude Health

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization

Virtual HealthTech conference powered by Impetus Digital: A Customer Story

White Papers and Resources | January 22, 2021 | Impetus Digital

In this customer story, we summarize one of the pilot projects conducted using our new and award-winning platform: InSite Event™.